Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Buyout before a FDA decision

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 01, 2023 10:45am

123 Views

Post# 35422746

RE:Buyout before a FDA decision

Nice to see M&A activity is still going strong. I also think it is in a Pharmas interest to get to TLT early in the process, Probably after BTD.. But who knows? TLT has reained under the radar for a long long time. They might get AA before a Pharma raises their eyebrow... But hey AA still should happen this year.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale